Quick Answer
Liver cirrhosis is the end-stage scarring of the liver caused by long-standing injury (alcohol, hepatitis, fatty liver, autoimmune disease). Dr. Anando Sengupta manages cirrhosis with cause-specific treatment, prevention of complications (variceal bleed, ascites, encephalopathy), 6-monthly liver cancer surveillance, and timely liver transplant referral when needed.
What is cirrhosis?
Cirrhosis is the final, irreversible stage of chronic liver damage. Normal liver tissue is replaced by fibrous scar that disrupts both the liver's function (synthesis of proteins, clearance of toxins) and its blood flow (causing portal hypertension).
Two stages of cirrhosis
| Compensated | Decompensated |
|---|---|
| No or minimal symptoms; near-normal life expectancy if cause is treated | Major complications: ascites, jaundice, variceal bleed, encephalopathy, kidney failure |
| Detected on routine LFT or ultrasound | Often presents as emergency hospitalisation |
Causes
- Alcoholic liver disease
- Chronic hepatitis B (most common chronic hepatitis in India)
- Chronic hepatitis C
- NAFLD / NASH — rising rapidly
- Autoimmune hepatitis
- Primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC)
- Wilson's disease, haemochromatosis, alpha-1-antitrypsin deficiency
- Drug-induced liver injury
- Cardiac cirrhosis (right heart failure)
Symptoms & signs
- Fatigue, weakness, weight loss
- Loss of appetite, nausea
- Jaundice (yellow eyes/skin)
- Easy bruising, prolonged bleeding
- Swelling of feet and abdomen (ascites)
- Itching, dark urine
- Confusion, sleep reversal, drowsiness (hepatic encephalopathy)
- Vomiting blood or black tarry stools (variceal bleed)
- Spider naevi, palmar erythema, gynaecomastia in men
Diagnosis & severity assessment
| Test | Purpose |
|---|---|
| LFT (bilirubin, AST, ALT, ALP, GGT, albumin), INR | Liver injury & synthetic function |
| Hepatitis B/C, autoimmune panel, ferritin, ceruloplasmin | Identify the cause |
| Ultrasound + Doppler / CT / MRI | Liver morphology, portal vein, splenomegaly, HCC screening |
| FibroScan | Non-invasive assessment of fibrosis |
| Upper GI endoscopy | Variceal screening |
| Child-Pugh & MELD scores | Severity, prognosis, transplant priority |
| Alpha-fetoprotein + 6-monthly USG | Liver cancer (HCC) surveillance |
Treatment
1. Treat the underlying cause
- Hepatitis B — lifelong antiviral therapy (entecavir, tenofovir)
- Hepatitis C — 8–12 weeks of direct-acting antivirals (cure rate >95%)
- Alcohol — complete abstinence; rehab support
- NAFLD — weight loss, diabetes control
- Autoimmune hepatitis — corticosteroids and azathioprine
2. Manage complications
- Varices: beta-blockers (propranolol, carvedilol) and/or endoscopic banding
- Ascites: salt restriction, diuretics, paracentesis with albumin for tense ascites
- Hepatic encephalopathy: lactulose + rifaximin
- SBP: third-generation cephalosporins + albumin
- Hepatorenal syndrome: terlipressin + albumin
- Pruritus: cholestyramine, rifampicin
3. HCC surveillance & transplant evaluation
Every 6 months — ultrasound and AFP. Suspicious nodules are evaluated with multiphase CT or MRI. Transplant referral is planned for advanced disease before crisis decompensation.
4. Nutrition & lifestyle
- 1.2–1.5 g/kg/day protein — including evening snack to prevent overnight muscle catabolism
- Salt < 2 g/day if ascites or oedema
- Fat-soluble vitamin (A, D, E, K) supplementation in cholestatic disease
- Vaccinate against hepatitis A, B, influenza, pneumococcus
- Avoid hepatotoxic herbal & over-the-counter drugs

